E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 8/2/2006 in the Prospect News Biotech Daily.

PDI at hold by Jefferies

Jefferies & Co., Inc. analyst David Windley rated PDI, Inc. at hold as the company's second-quarter revenues fell $6 million below the analyst's estimate. There is nothing much left for PDI to cut except the bone, according to the analyst. The company reported second-quarter earnings per share of $0.05 on $55 million in revenues, compared to Jefferies' estimate of $0.10 on $61.2 million and consensus of $0.12 on $63.3 million. Shares of the Saddle River, N.J.-based outsourced sales and marketing company were down $1.23, or 8.47%, at $13.29, on volume of 300,919 shares versus the three-month running average of 64,461 shares. (Nasdaq: PDII)


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.